Single or dual immune checkpoint inhibitor as adjuvant therapy in advanced melanoma

被引：1
|
作者：
Fukumoto, Takeshi [1 ]
Horita, Nobuyuki [2 ]
机构：
[1] Kobe Univ, Grad Sch Med, Dept Internal Related, Div Dermatol,Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan
[2] Yokohama City Univ, Grad Sch Med, Dept Pulmonol, Yokohama, Kanagawa, Japan
来源：
EUROPEAN JOURNAL OF CANCER | 2021年 / 147卷
关键词：
STAGE IV MELANOMA; DOUBLE-BLIND; IPILIMUMAB; NIVOLUMAB; PLACEBO;
D O I：
10.1016/j.ejca.2021.01.031
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：140 / 141
页数：2
相关论文
共 50 条
  • [11] Dermatomyositis Flare With Immune Checkpoint Inhibitor Therapy for Melanoma
    Thomas, Rachel
    Patel, Hamish
    Scott, Joshua
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (04)
  • [12] Adjuvant therapy for mucosal melanoma in the era of immune checkpoint inhibitors
    Nakamura, Yasuhiro
    Mori, Tatsuhiko
    CHINESE CLINICAL ONCOLOGY, 2024, 13 (01)
  • [13] THE RISK OF DIARRHEA AND COLITIS IN PATIENTS WITH ADVANCED MELANOMA UNDERGOING IMMUNE-CHECKPOINT INHIBITOR THERAPY
    Tandon, Parul
    Bourassa-Blanchette, Samuel
    Bishay, Kirles
    Parlow, Simon
    Laurie, Scott A.
    McCurdy, Jeffrey D.
    GASTROENTEROLOGY, 2018, 154 (01) : S60 - S60
  • [14] Immune Checkpoint Inhibitor Therapy as an Eye-Preserving Treatment for Locally Advanced Conjunctival Melanoma
    Hong, Bennett Yau-Bun
    Ford, Joshua R.
    Glitza, Isabella C.
    Cabala, Carlos A. Torres
    Tetzlaff, Michael
    Prieto, Victor G.
    Parker, Richard
    Daniel, Claire
    Esmaeli, Bita
    OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY, 2021, 37 (01): : E9 - E13
  • [15] THE RISK OF DIARRHEA AND COLITIS IN PATIENTS WITH ADVANCED MELANOMA UNDERGOING IMMUNE-CHECKPOINT INHIBITOR THERAPY
    Tandon, Parul
    Bourassa-Blanchette, Samuel
    Bishay, Kirles
    Parlow, Simon
    Laurie, Scott A.
    McCurdy, Jeffrey D.
    INFLAMMATORY BOWEL DISEASES, 2018, 24 : S42 - S42
  • [16] THE RISK OF DIARRHEA AND COLITIS IN PATIENTS WITH ADVANCED MELANOMA UNDERGOING IMMUNE-CHECKPOINT INHIBITOR THERAPY
    Tandon, Parul
    Bourassa-Blanchette, Samuel
    Bishay, Kirles
    Parlow, Simon
    Laurie, Scott
    McCurdy, Jeffrey D.
    GASTROENTEROLOGY, 2018, 154 (06) : S913 - S913
  • [17] Right ventricular and atrial strain in patients with advanced melanoma undergoing immune checkpoint inhibitor therapy
    Pohl, Julia
    Totzeck, Matthias
    Mincu, Raluca-, I
    Margraf, Simone M.
    Scheipers, Lena
    Michel, Lars
    Mahabadi, Amir A.
    Zimmer, Lisa
    Rassaf, Tienush
    Hendgen-Cotta, Ulrike B.
    ESC HEART FAILURE, 2022, 9 (05): : 3533 - 3542
  • [18] Immune Checkpoint Inhibitor Therapy in a Liver Transplant Recipient With Melanoma
    Schvartsman, Gustavo
    Perez, Kristen
    Sood, Gagan
    Katkhuda, Riham
    Tawbi, Hussein
    ANNALS OF INTERNAL MEDICINE, 2017, 167 (05) : 361 - 362
  • [19] Thrombocytopenia in patients with melanoma receiving immune checkpoint inhibitor therapy
    Shiuan, Eileen
    Beckermann, Kathryn E.
    Ozgun, Alpaslan
    Kelly, Ciara
    McKean, Meredith
    McQuade, Jennifer
    Thompson, Mary Ann
    Puzanov, Igor
    Greer, John P.
    Rapisuwon, Suthee
    Postow, Michael
    Davies, Michael A.
    Eroglu, Zeynep
    Johnson, Douglas
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
  • [20] THE ROLE OF IMMUNE CHECKPOINT INHIBITOR AS A SINGLE AGENT OR COMBINATION THERAPY IN ADVANCED THYROID CANCER
    Lee, Ju Young
    Park, Inae
    Nam, Myungwoo
    Low, Christmann
    Kim, Eugene
    Choi, Hansol
    Vagia, Elena
    Jung, Chan Mi
    Chae, Young Kwang
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A119 - A121
12345